ADMA Biologics, Inc. (ADMA)
10.66
+0.01
(+0.09%)
USD |
NASDAQ |
Apr 16, 15:01
ADMA Biologics Research and Development Expense (Quarterly) : 1.376M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.807M |
| Inovio Pharmaceuticals, Inc. | 9.921M |
| ANI Pharmaceuticals, Inc. | 12.26M |
| AtriCure, Inc. | 22.74M |
| Ligand Pharmaceuticals, Inc. | 3.511M |